Skip to main content
Main navigation
Rapid Reactions
Schizophrenia Foundations
Symptomatology
Patient Burden
Caregiver Perspectives
Psychopharmacology
Search
Main navigation
Rapid Reactions
Schizophrenia Foundations
Symptomatology
Patient Burden
Caregiver Perspectives
Psychopharmacology
Search
Psychopharmacology
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?
Muscarinic Myth Busters: Addressing Misconceptions of Muscarinic Receptor Activation in Schizophrenia
Of Musc and Men: The Exciting Potential of Muscarinic Receptor Modulation in the Treatment of Schizophrenia
Focus on Psychosis: Integrating Therapeutic Advances in the Treatment of Positive Symptoms of Schizophrenia
A New Frontier in Schizophrenia: Muscarinic Modulators and Their Role in Treatment
Advancing Schizophrenia Care: Improving Outcomes with Muscarinic Modulators
Why Should We Deprescribe Anticholinergics?
Patient Concerns About Deprescribing: How to Address Them
How to Taper Anticholinergic Medications Safely
Are There Guidelines for Deprescribing Anticholinergics?
Patient Case Studies: Successful Deprescription of Anticholinergics
Pagination
Current page
1
Page
2
Page
3
Page
4
Page
5
Next page
Next ›
Last page
Last »